Study at a glance
Do vitamin D supplements improve iron-related blood tests?
This page compares evidence on whether vitamin D supplements improve iron-related blood tests and red blood cell production. Vitamin D can affect hepcidin, which helps control iron availability, under experimental conditions. Clinical trials ask a different question: whether that effect leads to useful changes in people. Their results vary between populations.
What did the vitamin D trial in older adults find?
BEST-D included 305 adults aged 65 years or older. Participants received 2,000 or 4,000 IU of vitamin D3 daily, or an inactive treatment, for 12 months. Vitamin D levels rose substantially, but the measured iron-related blood tests did not change significantly compared with the inactive treatment. The doses describe the research, not instructions for personal use.
What did other vitamin D and iron studies show?
A trial in people with chronic kidney disease found no overall improvement in hepcidin or red blood cell production. Participants starting with lower vitamin D showed some improvement in haemoglobin, the oxygen-carrying substance in red blood cells, and a measure of iron availability. Those starting with higher vitamin D had a different response. A review combining trials found no significant overall change in haemoglobin or ferritin, a measure related to iron stores, but a modest improvement in iron availability.
Does better iron availability mean more red blood cells?
An improvement in iron availability does not guarantee increased red blood cell production. Starting vitamin D levels, iron stores, inflammation, kidney function and the body’s need for new red blood cells all affect the response. Vitamin D supplements alone do not reliably improve all iron measures, and these findings do not establish a general treatment for anaemia.
Read the full article below ↓Vitamin D can regulate hepcidin under experimental conditions, but clinical trials show that this mechanism does not produce the same iron outcome in every population. Long-duration studies in older adults and chronic kidney disease have found little or no overall improvement in hepcidin, ferritin, serum iron, transferrin saturation or haemoglobin despite large increases in vitamin D status. Other trials and subgroups show selective benefits. This heterogeneity is central to interpreting Vitamin D and Iron Metabolism. For the detailed evidence review, see Vitamin D Supplementation and Clinical Iron Markers Across Populations: Full Study.
BEST-D found no overall iron benefit
In 305 adults aged at least 65 years, 12 months of 2,000 or 4,000 IU vitamin D₃ daily substantially raised 25(OH)D but did not significantly alter hepcidin, ferritin, serum iron, transferrin, transferrin saturation or soluble transferrin receptor compared with placebo.
This demonstrates that raising vitamin D status does not necessarily change clinical iron physiology when another factor is not limiting the pathway.
CKD results depend strongly on context
A randomized CKD trial likewise found no overall improvement in hepcidin or erythropoiesis. Participants with lower baseline vitamin D showed some improvement in haemoglobin and transferrin saturation, while those with higher baseline status showed a different pattern.
Kidney function affects erythropoietin, hepcidin clearance and active vitamin D physiology, making Vitamin D and Kidneys important to interpretation.
Different biomarkers can move in different directions
A meta-analysis of randomized trials found no significant overall effect on haemoglobin or ferritin, while transferrin saturation showed a modest positive effect. This means improved iron availability cannot be assumed to produce a simultaneous increase in red-cell mass.
The result illustrates Vitamin D Status vs Vitamin D Effect: a biological response at one stage of a pathway does not guarantee a corresponding effect at every downstream stage.
The defensible interpretation
Vitamin D can participate in iron regulation, but supplementation is not a reliable stand-alone intervention for improving all iron markers. Baseline vitamin D status, iron stores, inflammation, renal function and erythropoietic demand materially change the response.
The evidence therefore supports physiological stratification rather than the claim that vitamin D supplementation generally improves anaemia or iron status.
Scientific sources
Effect of supplementation with vitamin D on biochemical markers of iron status and erythropoiesis in older people: BEST-D trial. PMID: 40452069.
The effect of high-dose vitamin D supplementation on hepcidin-25 and erythropoiesis in patients with chronic kidney disease. PMID: 36698076.
The effect of vitamin D supplementation on hemoglobin concentration: a systematic review and meta-analysis. PMID: 32013954.
Related reading
Osteomalacia as a Complication of Intravenous Iron Infusion: A Systematic Review of Case Reports
Randomized control trials (RCTs) have shown that certain intravenous iron preparations can induce high levels of fibroblast growth factor 23 (FGF‐23) and persistent hypophosphatemia.
Original paper ↗Read more →Alterations in regulators of the renal-bone axis, inflammation and iron status in older people with early renal impairment and the effect of vitamin D supplementation
Markers of the renal-bone axis, inflammation and iron status were investigated pre: and post-supplementation.
Original paper ↗Read more →Vitamin D, Inflammation and Anaemia-Related Iron Restriction: Study Summary
A concise review of vitamin D, inflammatory hepcidin signalling, iron restriction and anaemia-related physiology.
Read more →Vitamin D, Hepcidin, Iron Availability and Anaemia: Evidence Synthesis
Evidence synthesis integrating vitamin D, hepcidin, ferroportin, inflammation, iron availability and anaemia across mechanistic and clinical studies.
Read more →Circulating Fibroblast Growth Factor-23 Levels are Associated with an Increased Risk of Anemia Development in Patients with Nondialysis Chronic Kidney Disease
In this large-scale prospective cohort study, we investigated this relationship and examined whether high FGF23 levels increase the risk of incident anemia.
Original paper ↗Read more →Hyperphosphatemia is associated with anemia in adults without chronic kidney disease: results from the National Health and Nutrition Examination Survey (NHANES): 2005 to 2010
Using three cycles from the National Health and Nutrition Examination Survey (NHANES) (2005 to 2010), this study evaluated independent risk factors for hyperphosphatemia and hypophosphatemia.
Original paper ↗Read more →Non-mercaptalbumin, Oxidized Form of Serum Albumin, Significantly Associated with Renal Function and Anemia in Chronic Kidney Disease Patients
Oxidative stress plays a major role in development of cardiovascular disease in patients with chronic kidney disease (CKD).
Original paper ↗Read more →Serum Copper-to-Zinc Ratio and Oxidative Stress Are Associated with Anemia in Older Adults with Cardiovascular-Kidney-Metabolic Syndrome
We analyzed 2391 NHANES 2011 to 2016 participants ≥ 50 years of age with CKM stage I-IV.
Original paper ↗Read more →The effect of high-dose vitamin D supplementation on hepcidin-25 and erythropoiesis in patients with chronic kidney disease
We evaluated the change in markers of hepcidin expression, erythropoiesis, and iron status from baseline to week 12 and compared the change between the groups.
Original paper ↗Read more →Transgenic augmentation of erythroferrone in mice ameliorates anemia in adenine-induced chronic kidney disease
Anemia is a common and disabling complication of chronic kidney disease (CKD).
Original paper ↗Read more →Associations of epicardial fat with coronary calcification, insulin resistance, inflammation, and fibroblast growth factor-23 in stage 3-5 chronic kidney disease
Our primary objective was to determine the association between ssEFV and coronary artery calcification (CAC).
Original paper ↗Read more →Effect of Paricalcitol vs Calcitriol on Hemoglobin Levels in Chronic Kidney Disease Patients: A Randomized Trial
Therefore, we conducted a study to determine whether paricalcitol, compared to calcitriol, improves anemia in patients with chronic kidney disease (CKD).
Original paper ↗Read more →Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adults
Imbalances of blood biomarkers are associated with disease, and biomarkers may also vary non-pathologically across population groups.
Original paper ↗Read more →Left-ventricular diastolic dysfunction in Korean children with chronic kidney disease: data from the KNOW-Ped CKD study
This study aimed to assess the prevalence and risk factors of LVDD and the association between LVH and LVDD in Korean pediatric CKD patients.
Original paper ↗Read more →Leveraging practice-based research networks to accelerate implementation and diffusion of chronic kidney disease guidelines in primary care practices: a prospective cohort study
Motivated practices from four PBRNs received baseline and periodic performance feedback, academic detailing, and weekly practice facilitation for 6 months during wave I of the study.
Original paper ↗Read more →Probiotic Supplementation in Chronic Kidney Disease: Outcomes on Uremic Toxins, Inflammation, and Vascular Calcification from Experimental and Clinical Models
We aimed to evaluate the impact of a commercial probiotic (Probimel) supplementation on kidney function, mineral metabolism, inflammation and VC in both an experimental rat model and patients with advanced CKD and VC.
Original paper ↗Read more →The impact of a needs-oriented dental prophylaxis program on bacteremia after toothbrushing and systemic inflammation in children, adolescents, and young adults with chronic kidney disease
General prevalence of bacteremia after toothbrushing was 9.5% affecting 7 (26%) of the participants.
Original paper ↗Read more →Intact FGF23 and Markers of Iron Homeostasis, Inflammation, and Bone Mineral Metabolism in Acute Pediatric Infections
The aim of this prospective clinical study is to evaluate the association of i-FGF23 with hepcidin and markers of iron homeostasis, erythropoiesis, inflammation, and bone mineral metabolism in acute pediatric infections.
Original paper ↗Read more →Relationship between Serum Vitamin D and Leg Strength in Older Adults with Pre-Dialysis Chronic Kidney Disease: A Preliminary Study
This study aimed to investigate the relationship between a serum active vitamin D level and lower extremity muscle strength in elderly patients with pre-dialysis chronic kidney disease (CKD).
Original paper ↗Read more →Revisiting the Sarcopenic Index in Older Adults with Reduced Kidney Function: Association with EWGSOP2-Defined Probable Sarcopenia
Similar patterns were observed in participants with reduced kidney function.
Original paper ↗Read more →Vitamin D Supplementation and Clinical Iron Markers Across Populations: Full Study
Randomized evidence showing why vitamin D supplementation has variable effects on hepcidin, ferritin, transferrin saturation and haemoglobin.
Read more →Original sources
Effect of supplementation with vitamin D on biochemical markers of iron status and erythropoiesis in older people: BEST-D trial
The BEST-D trial, designed to establish the optimum dose of vitamin D3 for future trials, had 305 participants, aged 65 years or older, randomly allocated to 4000 IU vitamin D3 (n 102), 2000 IU vitamin D3 (n 102) or matching placebo (n 101).
Publication details
Effect of supplementation with vitamin D on biochemical markers of iron status and erythropoiesis in older people: BEST-D trial. PMID: 40452069.
The effect of high-dose vitamin D supplementation on hepcidin-25 and erythropoiesis in patients with chronic kidney disease
We evaluated the change in markers of hepcidin expression, erythropoiesis, and iron status from baseline to week 12 and compared the change between the groups.
Publication details
The effect of high-dose vitamin D supplementation on hepcidin-25 and erythropoiesis in patients with chronic kidney disease. PMID: 36698076.
The effect of vitamin D supplementation on hemoglobin concentration: a systematic review and meta-analysis
The effect of vitamin D supplementation on hemoglobin concentration: a systematic review and meta-analysis.
Publication details
The effect of vitamin D supplementation on hemoglobin concentration: a systematic review and meta-analysis. PMID: 32013954.